Symptom Science Literature Database©

References from Sleep Disturbance in Cancer

Akechi, T., Nakano, T., Akizuki, N., Okamura, M., Sakuma, K., Nakanishi, T., et al. (2003). Somatic symptoms for diagnosing major depression in cancer patients. Psychosomatics, 44(3), 244-248.

Anderson, K. O., Getto, C. J., Mendoza, T. R., Palmer, S. N., Wang, X. S., Reyes-Gibby, C. C., et al. (2003). Fatigue and sleep disturbance in patients with cancer, patients with clinical depression, and community-dwelling adults. Journal of Pain & Symptom Management, 25(4), 307-318.

Anderson, K. O., Getto, C. J., Mendoza, T. R., Palmer, S. N., Wang, X. S., Reyes-Gibby, C. C., et al. (2003). Fatigue and sleep disturbance in patients with cancer, patients with clinical depression, and community-dwelling adults

The efficacy of mindfulness-based stress reduction in the treatment of sleep disturbance in women with breast cancer. An exploratory study. Journal of Pain & Symptom Management, 25(4), 307-318.

Anonymous. (1999). Treatment of estrogen deficiency symptoms in women surviving breast cancer. Part 4: Urogenital atrophy, vasomotor instability, sleep disorders, and related symptoms. Oncology (Huntington), 13(4), 551-554, 557-560, 563 passim.

Barrows, K. A., & Jacobs, B. P. (2002). Mind-body medicine. An introduction and review of the literature. Med Clin North Am, 86(1), 11-31.

Buclin, T., Mazzocato, C., Berney, A., & Stiefel, F. (2001). Psychopharmacology in supportive care of cancer: a review for the clinician. IV. Other psychotropic agents. Supportive Care in Cancer, 9(4), 213-222.

Collins, J. J., Devine, T. D., Dick, G. S., Johnson, E. A., Kilham, H. A., Pinkerton, C. R., et al. (2002). The measurement of symptoms in young children with cancer: the validation of the Memorial Symptom Assessment Scale in children aged 7-12. Journal of Pain & Symptom Management, 23(1), 10-16.

Davidson, J. R., MacLean, A. W., & Brundage, M. D. (1998). Sleep disturbance in patients attending a regional cancer centre. Clinical & Investigative Medicine - Medecine Clinique et Experimentale(Suppl.), S93.

Davidson, J. R., MacLean, A. W., Brundage, M. D., & Schulze, K. (2002). Sleep disturbance in cancer patients. Social Science & Medicine, 54(9), 1309-1321.

de Jong, N., Courtens, A. M., Abu-Saad, H. H., & Schouten, H. C. (2002). Fatigue in patients with breast cancer receiving adjuvant chemotherapy: a review of the literature. Cancer Nursing, 25(4), 283-297; quiz 298-289.

Dunlop, R. J., & Campbell, C. W. (2000). Cytokines and advanced cancer. Journal of Pain & Symptom Management, 20(3), 214-232.

Ferrell, B. R., Virani, R., Smith, S., Juarez, G., National Cancer Policy, B., & Institute of, M. (2003). The role of oncology nursing to ensure quality care for cancer survivors: a report commissioned by the National Cancer Policy Board and Institute of Medicine. Oncology Nursing Forum Online, 30(1), E1-E11.

Fortner, B. V., Stepanski, E. J., Wang, S. C., Kasprowicz, S., & Durrence, H. H. (2002). Sleep and quality of life in breast cancer patients. Journal of Pain & Symptom Management, 24(5), 471-480.

Koliha, C. A. (2003). Obstructive sleep apnea in head and neck cancer patients post treatment ... something to consider? ORL - Head & Neck Nursing, 21(1), 10-14.

Koopman, C., Nouriani, B., Erickson, V., Anupindi, R., Butler, L. D., Bachmann, M. H., et al. (2002). Sleep disturbances in women with metastatic breast cancer. Breast Journal, 8(6), 362-370.

Kripke, D. F., Garfinkel, L., Wingard, D. L., Klauber, M. R., & Marler, M. R. (2002). Mortality associated with sleep duration and insomnia.[comment]. Archives of General Psychiatry, 59(2), 131-136.

Krueger, J. M., Majde, J. A., & Obal, F. (2003). Sleep in host defense. Brain Behav Immun, 17 Suppl 1, S41-47.

Mitropoulos, D., Anastasiou, I., Giannopoulou, C., Nikolopoulos, P., Alamanis, C., Zervas, A., et al. (2002). Symptomatic benign prostate hyperplasia: impact on partners' quality of life. European Urology, 41(3), 240-244; discussion 244-245.

Naeim, A., & Reuben, D. (2001). Geriatric syndromes and assessment in older cancer patients. Oncology (Huntington), 15(12), 1567-1577, 1580; discussion 1581, 1586, 1591.

Passik, S. D., Whitcomb, L. A., Kirsh, K. L., & Theobald, D. E. (2003). An unsuccessful attempt to develop a single-item screen for insomnia in cancer patients. Journal of Pain & Symptom Management, 25(3), 284-287.

Penson, D. F., & Litwin, M. S. (2003). The physical burden of prostate cancer. Urol Clin North Am, 30(2), 305-313.

Pistevou-Gombaki, K., Eleftheriadis, N., Plataniotis, G. A., Sofroniadis, I., & Kouloulias, V. E. (2003). Octreotide for palliative treatment of hepatic metastases from non-neuroendocrine primary tumours: evaluation of quality of life using the

EORTC QLQ-C30 questionnaire. Palliative Medicine, 17(3), 257-262.

Quesnel, C., Savard, J., Simard, S., Ivers, H., & Morin, C. M. (2003). Efficacy of cognitive-behavioral therapy for insomnia in women treated for nonmetastatic breast cancer. Journal of Consulting & Clinical Psychology, 71(1), 189-200.

Roychowdhury, D. F., Hayden, A., & Liepa, A. M. (2003). Health-related quality-of-life parameters as independent prognostic factors in advanced or metastatic bladder cancer. Journal of Clinical Oncology, 21(4), 673-678.

Rozans, M., Dreisbach, A., Lertora, J. J., & Kahn, M. J. (2002). Palliative uses of methylphenidate in patients with cancer: a review. Journal of Clinical Oncology, 20(1), 335-339.

Savard, J., & Morin, C. M. (2001). Insomnia in the context of cancer: a review of a neglected problem. Journal of Clinical Oncology, 19(3), 895-908.

Servaes, P., Verhagen, S., & Bleijenberg, G. (2002). Determinants of chronic fatigue in disease-free breast cancer patients: a cross-sectional study. Annals of Oncology, 13(4), 589-598.

Shapiro, S. L., Bootzin, R. R., Figueredo, A. J., Lopez, A. M., & Schwartz, G. E. (2003). The efficacy of mindfulness-based stress reduction in the treatment of sleep disturbance in women with breast cancer: an exploratory study. Journal of Psychosomatic Research, 54(1), 85-91.

Stevens, R. G., & Rea, M. S. (2001). Light in the built environment: potential role of circadian disruption in endocrine disruption and breast cancer. Cancer Causes & Control, 12(3), 279-287.

Walsh, D., Nelson, K. A., & Mahmoud, F. A. (2003). Established and potential therapeutic applications of cannabinoids in oncology.[comment]. Supportive Care in Cancer, 11(3), 137-143.

Wang, X. S., Giralt, S. A., Mendoza, T. R., Engstrom, M. C., Johnson, B. A., Peterson, N., et al. (2002). Clinical factors associated with cancer-related fatigue in patients being treated for leukemia and non-Hodgkin's lymphoma. Journal of Clinical Oncology, 20(5), 1319-1328.

Williams, A. F., Vadgama, A., Franks, P. J., & Mortimer, P. S. (2002). A randomized controlled crossover study of manual lymphatic drainage therapy in women with breast cancer-related lymphoedema. European Journal of Cancer Care, 11(4), 254-261.

Winningham, M. L. (2001). Strategies for managing cancer-related fatigue syndrome: a rehabilitation approach. Cancer, 92(4 Suppl), 988-997.